DNA Ginkgo Bioworks Holdings, Inc.
$8.32
Ginkgo Bioworks Holdings, Inc. (DNA) is expected to report earnings on February 4, 2027, after the market close. The stock has had a Post-Earnings Announcement Drift (PEAD) of -18.0% since its last earnings release on November 5, 2026.
Ginkgo Bioworks Missed Consensus Estimates
Thursday, November 5, 2026 · 4:05 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 4
Thursday · 4:05 PM ET
Earnings Whisper
-
vs -
Rev est $22.1M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$10.28
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Ginkgo Bioworks Holdings, Inc.
Ginkgo is building a platform to enable customers to program cells as easily as we can program computers.
Sector
Healthcare
Industry
Biotechnology
Held By 2 ETFs, by dollar flow
Charts powered in part by Lightweight Charts™ by TradingView.